Document Detail

Drugs and the fetus.
MedLine Citation:
PMID:  16601467     Owner:  NLM     Status:  MEDLINE    
PURPOSE OF REVIEW: Few drugs are licensed in pregnancy, and data on drug use in pregnancy are mainly retrospective and uncontrolled. Pregnancy exposure has increased recently to new classes of drugs, as they have been shown to be effective and well tolerated outside of pregnancy. RECENT FINDINGS: Anti-nausea therapies, H2-receptor and proton pump inhibitors appear to be safe. Metformin is being trialed for treatment in gestational diabetes and initial reports appear encouraging. Concern has been raised about statins in early pregnancy and should be avoided. New antiepileptic medication appears effective with low risk of abnormality. However, when combined with valproate, risks are still high. Selective serotonin reuptake inhibitors for depression appear to be effective, with likely low risk for teratogenesis, although neonatal behavioural syndrome following their use in the third trimester is a concern. Angiotensin II inhibitors should be avoided in the second and third trimesters of pregnancy. Smoking cessation programmes need to be reevaluated. SUMMARY: Information about safety of drugs and caution about prescribing in pregnancy should continue. Until large clinical trials are performed, the risk/benefit ratio of drugs during pregnancy will remain uncertain.
Phillipa M Kyle
Related Documents :
8287577 - Pregnancy associated osteoporosis.
19961047 - Possible long-term teratogenic effect of isotretinoin in pregnancy.
8448417 - Practices of epilepsy during pregnancy: a survey of canadian neurologists.
11124717 - Antiarrhythmic drugs in pregnancy.
18956427 - Three-dimensional inversion rendering in the first- and early second-trimester fetal br...
20979447 - Predicting survival of periviable fetuses using nichd fetal heart rate categories.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Current opinion in obstetrics & gynecology     Volume:  18     ISSN:  1473-656X     ISO Abbreviation:  Curr. Opin. Obstet. Gynecol.     Publication Date:  2006 Apr 
Date Detail:
Created Date:  2006-04-07     Completed Date:  2008-06-20     Revised Date:  2008-10-07    
Medline Journal Info:
Nlm Unique ID:  9007264     Medline TA:  Curr Opin Obstet Gynecol     Country:  England    
Other Details:
Languages:  eng     Pagination:  93-9     Citation Subset:  IM    
Obstetrics and Gynaecology, Christchurch School of Medicine and Health Sciences, University of Otago, New Zealand.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Drug Approval
Fetal Development / drug effects*
Fetus / drug effects*
Prenatal Exposure Delayed Effects*
Reg. No./Substance:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Recent findings on laser treatment of twin-to-twin transfusion syndrome.
Next Document:  Fetal anaemia as a cause of fetal injury: diagnosis and management.